WebDec 12, 2014 · UPDATED December 16, 2014 — Results from the huge international Suppression of Ovarian Function Trial (SOFT) are practice changing for the adjuvant treatment of premenopausal women with early ... WebHistorical early treatment effects of adjuvant endocrine therapy for breast cancer in high-risk subgroups: Reanalysis of BIG 1-98, SOFT and TEXT. Regan MM, Niman SM, Fleming GF, Walley B, Viale G, Thurlimann BJK, Loi S, Colleoni M, Pagani O, Francis PA. Journal of Clinical Oncology. 2024; 40 (16 suppl):ASCO Abstract #508, Abstract.
Case 2: SABCS 2024 Updates on SOFT and TEXT Trials for HR
WebDec 11, 2014 · In 2003, the International Breast Cancer Study Group (IBCSG) initiated two randomized, phase 3 trials, the Suppression of Ovarian Function Trial (SOFT) and the … WebMar 1, 2024 · Clinical Trial Updates provide an opportunity to dissemina ... Long-Term Follow-Up of the Combined TEXT and SOFT Trials J Clin Oncol. 2024 Mar 1;41(7):1376 … csc exam reviewer app
Breast Cancer 2014: SOFT Proves Year
Web12-year follow-up of SOFT and TEXT trials - Meredith M. Regan, ScD, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, gives an update on the … WebJun 16, 2015 · In SOFT and TEXT, overall survival differences were not significant, but there were more deaths in the exemestane and OFS group than in the tamoxifen plus OFS group … WebFeb 16, 2024 · In 2013, two randomized trials were initiated by the International Breast Cancer Study Group: The Suppression of Ovarian Function Trial (SOFT) and the Tamoxifen and Exemestane Trial (TEXT). The results of the SOFT and TEXT trials created a paradigm shift in the management of high risk premenopausal women with estrogen receptor … csc exam reviewer 2021